17-10301618-T-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_003802.3(MYH13):c.5753A>T(p.Glu1918Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,614,226 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000072 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000028 ( 0 hom. )
Consequence
MYH13
NM_003802.3 missense
NM_003802.3 missense
Scores
10
5
4
Clinical Significance
Conservation
PhyloP100: 7.93
Genes affected
MYH13 (HGNC:7571): (myosin heavy chain 13) Predicted to enable microfilament motor activity. Predicted to be involved in muscle contraction. Predicted to act upstream of or within cellular response to starvation. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.2964084).
BS2
High AC in GnomAd4 at 11 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYH13 | NM_003802.3 | c.5753A>T | p.Glu1918Val | missense_variant | 40/41 | ENST00000252172.9 | |
LOC107985004 | XR_007065617.1 | n.95+9705T>A | intron_variant, non_coding_transcript_variant | ||||
LOC107985004 | XR_001752791.3 | n.95+9705T>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYH13 | ENST00000252172.9 | c.5753A>T | p.Glu1918Val | missense_variant | 40/41 | 1 | NM_003802.3 | P1 | |
MYH13 | ENST00000621918.1 | c.5753A>T | p.Glu1918Val | missense_variant | 38/39 | 1 | P1 | ||
ENST00000609088.1 | n.94+9705T>A | intron_variant, non_coding_transcript_variant | 4 | ||||||
MYH13 | ENST00000418404.8 | c.5753A>T | p.Glu1918Val | missense_variant | 39/40 | 5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152226Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
11
AN:
152226
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000123 AC: 31AN: 251208Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135844
GnomAD3 exomes
AF:
AC:
31
AN:
251208
Hom.:
AF XY:
AC XY:
17
AN XY:
135844
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000280 AC: 41AN: 1461882Hom.: 0 Cov.: 30 AF XY: 0.0000275 AC XY: 20AN XY: 727244
GnomAD4 exome
AF:
AC:
41
AN:
1461882
Hom.:
Cov.:
30
AF XY:
AC XY:
20
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152344Hom.: 0 Cov.: 32 AF XY: 0.0000805 AC XY: 6AN XY: 74498
GnomAD4 genome
AF:
AC:
11
AN:
152344
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
74498
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
12
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 09, 2021 | The c.5753A>T (p.E1918V) alteration is located in exon 40 (coding exon 38) of the MYH13 gene. This alteration results from a A to T substitution at nucleotide position 5753, causing the glutamic acid (E) at amino acid position 1918 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;D;D
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
.;D;.
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
H;H;H
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;.;D
REVEL
Pathogenic
Sift
Pathogenic
.;.;D
Sift4G
Pathogenic
D;D;D
Polyphen
D;D;D
Vest4
MutPred
Loss of ubiquitination at K1923 (P = 0.0213);Loss of ubiquitination at K1923 (P = 0.0213);Loss of ubiquitination at K1923 (P = 0.0213);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at